In a Phase 1a escalating clinical trial, autologous mesenchymal stem cell infusion for renovascular disease increases blood flow and the glomerular filtration rate while reducing inflammatory biomarkers and blood pressure

Abdelrhman Abumoawad, Ahmed Saad, Christopher M. Ferguson, Alfonso Eirin, Sandra M. Herrmann, LaTonya J. Hickson, Busra B. Goksu, Emily C. Bendel, Sanjay Misra, James F. Glockner,

Kidney International · 2019 · 102 citations · 37 references

DOIFull text

Open access

Concepts

References

37